The first CBD-based prescription drug in the US has finally been approved by FDA. This post from Business Insider India highlights why this welcome decision is worrying some marijuana startups. Summary: This week's historic decision by the Food and Drug Administration to approve Epidiolex, the first prescription drug derived from marijuana, has left cannabis startups in ... Continue Reading
Epidiolex
CBD Deemed a Medicine, But Sellers in a Bind
CBD has been deemed a legitimate medicine by the UK government, but sellers have to stop selling it in 28 days. This post from VICE discusses the far-reaching impact of this decision! "It's potentially a health disaster for tens of thousands of people." The government arm responsible for regulating medicine has deemed CBD (cannabidiol) – a component of hemp used to treat ... Continue Reading
Treating Epilepsy with CBD: What Science Says
Research done so far suggests that CBD, a compound of cannabis, could be a good way to reduce and treat epilepsy. This post from Green Rush Daily highlights what cannabis is doing for epilepsy! One of the hottest fields being studied right now in the world of medical cannabis has to do with figuring out if the plant can be used to treat epilepsy. In particular, people are ... Continue Reading
GW Pharmaceuticals Reports Positive Results of Epidiolex® Phase 3 Trial
GW Pharmaceuticals reports the results of phase 3 study of Epidiolex for treatment of Dravet syndrome, a rare and severe form of epilepsy. This post from Clinical Leader gives the study overview and discusses the phase 3 trial results. GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, ... Continue Reading
Big Pharma Cannabis Might Hit Market in 2016
Big pharma corporations are perhaps waiting for the rescheduling and legalization of cannabis much more than you and me and they stand to gain a lot more too. This article from The Huffington Post discusses how big pharma-produced cannabis products are on their way to America’s billion dollar pharmaceutical market. For those hoping that Big Pharma could still be blocked from ... Continue Reading